Literature DB >> 24988834

Horizontal strabismus surgical outcomes in a teaching hospital.

Z Idrees, I Dooley, G Fahy.   

Abstract

Strabismus may result in impaired stereopsis, diplopia, undesirable appearance, amblyopia and negative psychological impact. This study provides epidemiological and surgical outcome information about patients attending University College Hospital Galway requiring strabismus surgery. We report a retrospective analysis of 75 consecutive patients, who underwent horizontal strabismus surgery. Sixty-one (81.3%) patients had clinically significant refractive errors, hyperopia being the most common. Thirty-four (45.3%) patients had amblyopia and nine (12%) required further treatment. A cosmetically acceptable result with a post-operative ocular deviation within 25 prism dioptres of straight (grade 2) was achieved in 70/75 (93.3%) of patients. The overall mean change in ocular deviation per mm of muscle operated was 3.25 prism dioptre/mm. The outcomes of strabismus surgery in an Irish hospital compare very favourably with other jurisdictions. This data will help plan service delivery.

Entities:  

Mesh:

Year:  2014        PMID: 24988834

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  3 in total

1.  Outcomes of adjustable strabismus surgery in an Irish University Hospital.

Authors:  Alex Ferdi; Rory Kelly; Pat Logan; Ian Dooley
Journal:  Int Ophthalmol       Date:  2016-11-08       Impact factor: 2.031

2.  Burden of Ocular Motility Disorders at a Tertiary Care Institution: A Case to Enhance Secondary Level Eye Care.

Authors:  Rohit Saxena; Digvijay Singh; Shiva Prasad Gantyala; Sneha Aggarwal; Murli Manohar Sachdeva; Pradeep Sharma
Journal:  Indian J Community Med       Date:  2016 Apr-Jun

3.  Extraocular muscle resection, recession length and surgery outcome modelling in strabismus treatment: a pilot study.

Authors:  Ala Paduca; Oleg Arnaut; Eugeniu Bendelic; Jan Richard Bruenech; Per Olof Lundmark
Journal:  BMJ Open Ophthalmol       Date:  2021-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.